Fate Therapeutics Inc. sell StockNews.com
Start price
11.05.24
/
50%
€4.15
Target price
11.05.25
-
Performance (%)
-21.69%
Price
24.05.24
€3.25
Summary
This prediction is currently active. The price of Fate Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.69%. This prediction currently runs until 11.05.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Fate Therapeutics Inc. | -9.521% |
iShares Core DAX® | -0.205% |
iShares Nasdaq 100 | 1.613% |
iShares Nikkei 225® | -0.740% |
iShares S&P 500 | 0.267% |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat